Navigation Links
Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
Date:1/17/2008

Reaffirms Previous Guidance for 2007

MADISON, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it will report results for the fourth quarter and year ended December 31, 2007 and provide financial guidance for 2008 on February 21, 2008, instead of the previously scheduled date of January 29.

The company is rescheduling its report of fourth quarter and full-year 2007 results in order to provide time to attempt to make further progress in its ongoing effort to settle with the government claims associated with the government's investigation in connection with NID, a test kit manufacturing subsidiary the company closed in 2006. While the company is working diligently to reach such a settlement prior to its report of earnings for the fourth quarter and year ended December 31, 2007, there can be no assurance as to when or whether a settlement may be reached, or as to its terms. Additional information regarding this matter is available in the company's September 30, 2007 Quarterly Report on Form 10-Q, including Footnote 7 to the Financial Statements.

The company reaffirms its 2007 guidance for revenues of between $6.6 billion and $6.7 billion, and earnings per diluted share from continuing operations of between $2.84 and $2.91, before $0.04 per share in special charges recorded in the first quarter of 2007.

Quest Diagnostics will hold its fourth quarter conference call on February 21, 2008 at 8:30 A.M. Eastern Time. A simulcast of the call is available by dialing 210-839-8500 -- PASSCODE: 3214469 and via the Internet at: h
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
2. Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference
3. ADM, MGSC and ISGS Announce Carbon Sequestration Project
4. SleepQuest Launches Updated Web Site
5. Quest Diagnostics Declares Quarterly Cash Dividend
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
8. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
9. Sinovac Requests Extension for Annual Shareholders Meeting
10. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
11. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... The maker community is a contemporary ... They focus on learning practical skills while applying them ... bringing their ideas to life via crowdfunding. A subgroup ... making projects using biology. Glowing Plant has worked for ... them glow with bioluminescence genes, and has now pursued ...
(Date:5/23/2013)... May 23, 2013 VG Energy, an ... with DAK Renewable Research to conduct field trials ... VG Energy is a majority owned subsidiary of ... VG Energy,s exclusively licensed compound LipidMax selectively ... yield in plants, possessing a wide variety of ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... 23, 2013 On April 19th the ... supermarkets to search for the growing antibiotic resistant bacteria ... from a year long study were released late last ... specifically meats, over previous years. For those suffering from ... of antibiotic resistant bacteria in food, may eventually help ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2
... 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS;,Nasdaq: PXSL) today ... for its asthma management product, Aridol., "This ... Pharmaxis Chief,Executive Officer Dr Alan Robertson. "Korea is ... Aridol in Asia. There are an estimated 2.5 ...
... cheaper and more efficient is the aim of a ... and Q1 NanoSystems. The university and the company, based ... exclusive licensing of a package of jointly-owned intellectual property ... The agreement covers inventions that enable manufacture of very ...
... GPRO ) announced today that the Company will ... on Wednesday, February 13,2008 at approximately 4:00 p.m. Eastern ... call at 4:30 p.m. ET hosted by Henry L. ... senior,vice president, finance, and chief financial officer., The ...
Cached Biology Technology:Pharmaxis' Aridol Gains First Asian Approval 2Solar energy technology licensed 2Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call 2
(Date:5/22/2013)... changes in cellular DNA can endanger the whole organism, ... Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich now report how ... double helix. , The DNA in our cells controls ... our bodies. The instructions for this are encoded in ... DNA, the bases adenine (A), cytosine (C), guanine (G) ...
(Date:5/22/2013)... life scientists provide important new details on how climate ... online May 21 in the Journal of Animal ... making accurate predictions and informing policymakers of how species ... , "There is a growing recognition among biologists ... one another, and that this is going to have ...
(Date:5/22/2013)... in the biodiversity of pollinating insects and wild plants ... study. , Researchers led by the University of Leeds ... evidence of dramatic reductions in the diversity of ... 1950s and 1980s. , But the picture brightened markedly ... biodiversity losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... "Red Tide" event that occurred off the coast of ... of some 200 sea turtles, according to test results ... other organizations. , Responding to requests from the Salvadoran ... assistance, WCS veterinary pathologist Dr. Julie White journeyed to ...
... of Texas at Austin studying electric fish have gained new ... neurons. , Their finding, published in the Feb. 16 ... and neural disorders like epilepsy in humans. , Dr. Harold ... fish zap each other in dark waters, their neurons store ...
... from a new study indicate that hybrid laboratory antibodies ... safe and effective way to treat the serious complications ... protect against the deadly disease itself. The study, led ... Infectious Diseases (NIAID), part of the National Institutes of ...
Cached Biology News:Red Tide causes sea turtle die-off in El Salvador 2Mechanism for memory revealed in neurons of electric fish 2Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 2Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 3